drugset / Trial / NCT00167739

Treatment of Malaria With Quinine Plus Sulfadoxine-Pyrimethamine

NCT00167739

Phase 4 Completed 50 enrolled Albert Schweitzer Hospital
Non-randomizedSingle-groupOpen-labelTreatment

Summary

Quinine remains the treatment of choice of hospitalised malaria cases. The long treatment duration of 7 days, and adverse reactions often hamper its adequate use. Reducing the treatment duration by adding sulfadoxine-pyrimethamine may enhance compliance and reduce side effects. The efficacy of a 3-day treatment of quinine plus sulfadoxine-pyrimethamine for the treatment of hospitalised, uncomplicated malaria cases was assessed.

Timeline

Start
2003-04
Primary completion
Completion
2004-02

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Quinine Small molecule Intravenous
Subject Sulfadoxine-pyrimethamine Small molecule Oral

Indications